Ribomic Inc.
Status: Publicly traded
Direct answer
Ribomic Inc. is publicly traded on JPX under the ticker 4591.T.
Ribomic Inc. is a Japanese biopharmaceutical company dedicated to identifying and advancing medicinal compounds. The firm employs RNA aptamers in its drug development efforts, targeting various significant health issues such as wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma. Furthermore, Ribomic...
Can you invest in Ribomic Inc.?
Yes. Ribomic Inc. is publicly traded on JPX under the ticker 4591.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ribomic Inc.
Detailed equity research is provided by MarketSnap.